SG/PUT/FRESENIUS/25/0.1/20.09.24 Share Price

Warrant

DE000SU9B061

Market Closed - Bid/Ask 01:12:40 02/07/2024 am IST
0.032 EUR -20.00% Intraday chart for SG/PUT/FRESENIUS/25/0.1/20.09.24
Current month-22.50%
1 month-11.43%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
02/24/02 0.032 -20.00%
28/24/28 0.04 +8.11%
27/24/27 0.037 0.00%
26/24/26 0.037 +8.82%
25/24/25 0.034 -10.53%

Real-time Boerse Frankfurt Warrants

Last update July 02, 2024 at 01:12 am IST

More quotes

Static data

Product typeWarrants
Buy / SellPUT
Underlying FRESENIUS SE & CO. KGAA
IssuerLogo Issuer Société Générale Société Générale
WKN SU9B06
ISINDE000SU9B061
Date issued 14/02/2024
Strike 25
Maturity 20/09/2024 (81 Days)
Parity 10 : 1
Emission price 0.2
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 0.23
Lowest since issue 0.024
Delta-0.16x
Omega 12.53
Premium12.93x
Gearing78.61x
Moneyness 0.8834
Difference Strike -3.3
Difference Strike %-13.20%
Spread 0.01
Spread %24.39%
Theoretical value 0.0380
Implied Volatility 30.84 %
Total Loss Probability 79.83 %
Intrinsic value 0.000000
Present value 0.0380
Break even 24.62 €
Theta-0x
Vega0x
Rho-0x

Company Profile

Fresenius SE & Co. KGaA specializes in designing, producing, and selling medical drugs, equipment, and devices used in clinical hospitalization and at home. Net sales break down by activity as follows: - hospital administration and engineering (64.3%; Fresenius Vamed and Fresenius Helios): management of technical facilities and medical equipment, hospital management, design and production of medical equipment for the pharmaceutical sector, etc.; - perfusion and clinical nutrition (35.7%; Fresenius Kabi): sales of parenteral and oral nutrition products, perfusion and vascular filling equipment, transfusion materials, generic injectable products, home medical assistance services in the areas of perfusion, nutrition, and oxygen therapy, etc. Net sales are distributed geographically as follows: Europe (72.4%), North America (12.3%), Asia/Pacific (7.3%), Latin America (6.4%) and Africa (1.6%).
Sector
-
More about the company

Ratings for Fresenius SE & Co. KGaA

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Fresenius SE & Co. KGaA

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
16
Last Close Price
27.88 EUR
Average target price
37.26 EUR
Spread / Average Target
+33.63%
Consensus